Last reviewed · How we verify
NCT06044402
Different Tidal Volume on Oxygenation, Respiratory Mechanics, and Pulmonary Complications in Older Patients Undergoing Trendelenburg Pneumoperitoneum Surgery
NA trial testing group L (Vt 6 ml/kg) in Trendelenburg in 130 participants. Status unknown.
30 November 2024
Quick facts
| Lead sponsor | dong zhang |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 130 |
| Start date | 8 October 2023 |
| Primary completion | 30 November 2024 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- group L (Vt 6 ml/kg)
- group I (Vt 8 ml/kg)
Conditions studied
- Trendelenburg — all drugs for Trendelenburg →
- Neumoperitoneum — all drugs for Neumoperitoneum →
- Oxygenation — all drugs for Oxygenation →
- Respiratory — all drugs for Respiratory →
Sponsor
dong zhang — full company profile →
Who can join
66 and older, any sex, with Trendelenburg or Neumoperitoneum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators want to assess the effect of intraoperative low tidal volume vs intermediate tidal volume on respiratory mechanics, oxygenation and pulmonary complications in older patients undergoing Trendelenburg pneumoperitoneum surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06044402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trendelenburg
Currently open trials in the same condition.
- NCT06911736 — Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence · NA · recruiting
Other dong zhang trials
Trials by the same sponsor.
- NCT07085455 — The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN) · NA · recruiting
- NCT05416866 — Transversus Abdominis Plane Block Plus Quadratus Lumborum Block or Retrolaminar Block of Multiple Injections for Postope · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06044402 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by dong zhang
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06044402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing